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angle of the inclined screen test, and physical strength was evaluated by
the time to survive in water (forced swimming method). GAA and CRT
concentrations in serum, muscle and other organs were signiﬁcantly
decreased in CRF rats. GAA administrations signiﬁcantly increased CRT
content in muscle, and improved muscle capabilities dose-dependently.
muscle power physical strength
sliding angle; 1 swimming time; min
Sham 55.270.9 52.073.8
CRF(GAA 0) 42.371.9* 21.971.2*
CRF(GAA 10 mg) 47.471.3*$ 25.571.1*$
CRF(GAA 100 mg) 48.872.1*$ 29.073.3*$
*; po0.05 vs Sham $; po0.05 vs GAA 0
In conclusion, we demonstrated a deﬁciency of GAA and CRT, and muscle
weekness in CRF rats. However, oral GAA supplementation could recover
muscle content of CRT and muscle capabilities in these rats.
http://dx.doi.org/10.1016/j.krcp.2012.04.582
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IMPACT OF IDPN ON KT/V
Dukkipati R, Moore E., VanBolt G, Kalantar-Zadeh K
UCLA Torrence California Pentec Health Inc. Boothwyn, PA, USA.
The administration of intradialytic parenteral nutrition (IDPN) and the
impact it has on Kt/V has not been thoroughly examined. The available
literature addressing the inﬂuence of IDPN on Kt/V is limited and the
observations are conﬂicting. Some studies have observed little or no signiﬁcant
change with IDPN administration. In contrast, one randomized, crossover study
by McCann et al. of patients receiving IDPN observed a signiﬁcant decrease.
When amino acid (AA), dextrose and lipid components were administered a
signiﬁcant reduction in mean Kt/V resulted. When solutions containing only AA
were administered, Kt/V was signiﬁcantly less then when IDPN was withheld
Administration of IDPN without AA resulted in a mean Kt/V not signiﬁcantly
different from the mean Kt/V when IDPN was withheld. AA containing IDPN
reduced mean Kt/V by 18–23%. By personal communication with McCann, it
was thought the amount of carbohydrate (CHO) determined whether the Kt/V
was impacted when they studied further (unpublished). The authors found that
by increasing the CHO, the Kt/V was not impacted (lower) and theorized that
inadequate CHO resulted in catabolized protein generating urea. To investigate
this further, a retrospective analysis was performed of the Pentec Health IDPN
internal data base consisting of 489 patients that met inclusion and exclusion
criteria. For this group: the age was 66.23þ13.38 years; BMI was 25.79þ56;
239 males (49%) and 250 females (51%); 304 patients with DM (62%); 430
patients with HTN (88%). Baseline albumin was 2.98þ38 g/dL and baseline
creatinine was 6.03þ2.10 mg/dL. Results are below Table
Kt/V (mean þ SD)
Baseline Month 1 Month 2 Month 3
1.65þ .34 1.44þ .36 1.43þ .35 1.44þ .34
A repeated measures ANOVA indicated a statistically signiﬁcant
difference (po0.0001). A Tukey’s adjustment resulted in non-signiﬁcant
differences between month 1 and month 2 (p¼0.995), month 1 and month
3 (p¼0.987), and month 2 and month 3 (p¼0.936). In conclusion, the
initial decrease in Kt/V was followed by a period of stabilization, and the
mean Kt/V never dropped below the KDOQI recommendation of 1.2.
http://dx.doi.org/10.1016/j.krcp.2012.04.583
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A FULL COLOR VISUAL EDUCATING TOOL TO IMPROVE RENAL
DIET COMPLIANCE
Cecile Verseput
Johannesburg, Gauteng, South Africa.
The objective is to simplify Renal diet education of a newly diagnosed,
illiterate/non-English speaking CKD patient by using a 5 step concept that is
explained by a fully illustrated color manual. The 5 steps to be followed are as
follows:
Step 1. What foods are eaten daily? The renal dietitian is faced with many
challenges when taking a diet history & educating a newly diagnosed CKD
patient. It is of utmost importance to tailor education to speciﬁc patient’s
needs & to adapt the diet prescription to the patient’s literacy level, culture,
socio-economic circumstances & eating habits.
Step 2. How kidneys work. The damaged kidney is portrayed as a sieve with
very ﬁne mesh that does not allow normal kidney functions. Once the patient
understands that his uremic symptoms are related to diet & damaged
kidneys, he is willing to change his old eating habits. RRT is explained
visually.
Step 3. What to eat. The calculated, technical diet prescription is explained
in an understandable way by a visual tool called ‘‘The renal plate’’ that was
speciﬁcally developed. The Renal plate is based on adjusting the Basic 3 Food
Groups by making use of the South African Renal exchange lists.
Step 4. What not to eat. Foods to avoid due to high sodium, phosphate &
potassium are presented by illustrations.
Step 5. How much to eat. Portion sizes are addressed through visuals since
‘‘The renal plate’’ only focuses on types of foods in a speciﬁc food group, not
on quantity of each food group to be eaten.
Compliance to a renal diet is an integral part of patient care. If
understandable renal diet education is linked to uremic symptoms & starts as
soon as the patient is diagnosed, there is far better future diet compliance &
disease outcome.
http://dx.doi.org/10.1016/j.krcp.2012.04.584
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PROMOTES RENAL EXCRETION OF PHOSPHATE IN HEMODIALYSIS
PATIENTS WITH RESIDUAL RENAL FUNCTION
Mengjing Wang, Li You, Haiming Li, Yong Lin, Zhijie Zhang,
Chuanming Hao, Jing Chen
Shanghai Medical College, Fudan University, Shanghai, China
Fibroblast growth factor-23 (FGF-23) regulates phosphate metabolism and
elevated levels occur in patients with kidney disease and are associated with
smortality in maintenance hemodialysis (MHD) patients. Residual renal
function (RRF) presumably improves phosphate metabolism in MHD patients.
We investigated the role of circulating FGF-23 on urinary phosphate excretion
and phosphate balance in 134 MHD patients. Demographics, laboratory data,
and excretion capacity of phosphate were recorded. We used multivariable
regression to analyze the relationship of serum phosphate with other factors
and of the tubular reabsorption rate of phosphate with other factors. Patients
with high urinary output (4200mL/day) had lower serum phosphate, calcium,
iPTH, and FGF-23 than patients with low urinary output (o 200 mL/day). The
independent risk factors for elevated serum phosphate were nPNA, iPTH, and
FGF-23 in patients with low urinary output, and female gender and GFR in
patients with high urinary output. In high urinary output patients, the weekly
phosphate excretion was 300 to 1500 mg, the renal contribution to weekly
phosphate elimination was about 15% when GFR o 2 mL/min, 25% when 2r
GFR o 5mL/min, and 40%when GFR Z 5mL/min. The tubular reabsorption of
phosphate (44% 7 19%) was nearly 50% of the normal level, much lower than
that of sodium, chlorine, and calcium which ranged from 85% to 99%. Elevated
circulating FGF-23 was signiﬁcantly associated with decreased tubular
phosphate reabsorption after adjusting for GFR and serum phosphate (b¼-
0.147, p¼0.003). In conclusion, RRF is associated with signiﬁcant capacity to
excrete phosphate and high levels of FGF-23 promote phosphate excretion in
remnant nephrons.
http://dx.doi.org/10.1016/j.krcp.2012.04.585
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IMPACT OF NLRP3 INFLAMMASOME ON THE DEVELOPMENT OF
HYPERTENSION AND RENAL AND CARDIAC HYPERTROPHY IN 2K1C AND
DOCA/SALT MICE
Q. Wang, A So, J. Nussberger, J. Tschopp, M. Burnier
Service of Nephrology, Rheumatology, and Angiology, CHUV; Department of
Biochemistry, Lausanne University, Switzerland
NLRP3 inﬂammasome is formed by NLRP3, the adaptor ASC, and caspase-1,
functions as a sensor of danger signals and triggers processing and release of
interleukin-1beta (IL-1b). Recent animal studies demonstrate that NLRP3
inﬂammasome promotes renal inﬂammation. However, little is known on the
role of NLRP3 in hypertension. We have investigated the effect of NLRP3
inﬂammasome on blood pressure, plasma renin activity and concentration
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